Non-HDL Cholesterol, Apolipoprotein B, and HDL Cholesterol With Risk of Sudden Cardiac Death: the ARIC Study

If sudden cardiac death is largely a complication of atherosclerosis, then the markers that best measure atherogenic particles should predict it. This large community study tested that logic.

Following nearly 14,000 adults free of heart disease for two decades, the ARIC investigators found that the atherogenic-particle measures — non-HDL cholesterol and apolipoprotein B — were each significantly associated with sudden death, with the highest quartile carrying roughly 1.5 to 1.8 times the risk. HDL cholesterol ran the other way, protective. Tellingly, the associations for non-HDL and apoB held up even after accounting for LDL cholesterol, hinting that they capture risk that plain LDL misses.

The thread connecting this to the rest of the lipid literature is consistent: the count of atherogenic particles, not just the cholesterol they carry, tracks hard outcomes — here, the hardest outcome of all. It adds sudden death to the list of endpoints apoB and non-HDL help predict.

We rate the evidence strong. It is a rigorous, long-term cohort analysis, with the usual caveat that it establishes prediction rather than proving that acting on these markers prevents sudden death.